a total of 208 patients underwent brain biopsy for presumptive herpes simplex encephalitis and were randomized to receive either vidarabine , vira-a , at 15 mg/kg/day , or acyclovir , at 30 mg/kg/day for ten days .
C0276226
herpes simplex
C0001367
acyclovir